Somerville, MA, United States of America

Guokui Qin

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Qt Holdings Corp. Active years: 2017-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guokui Qin. Retrieved from https://idiyas.com/inventor/guokui-qin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Guokui Qin: Innovator in Cell Separation and T Lymphocyte Expansion

Introduction

Guokui Qin is a notable inventor based in Somerville, MA (US). He has made significant contributions to the fields of cell separation and T lymphocyte expansion, holding a total of 2 patents. His work is pivotal in advancing medical technologies that enhance cell therapy and treatment methodologies.

Latest Patents

Guokui Qin's latest patents include innovative solutions for cell separation and T lymphocyte activation. The first patent, titled "Compositions, devices, and methods for cell separation," features a substrate and compositions that enable the isolation of a specific population of cells from a general population. This invention allows for the recovery of unlabeled, viable, and functional cells, enriching the isolated population for one or more target groups. The second patent, "Methods and compositions for activation or expansion of T lymphocytes," presents a complex that binds to, stimulates, and expands a desired T cell population. This complex facilitates the separation of the target population from a sample and can be gently dissociated after the desired T cell population is obtained, representing a safe and efficient approach for clinical applications.

Career Highlights

Guokui Qin is associated with Qt Holdings Corp, where he continues to innovate and develop technologies that have a significant impact on the medical field. His work is characterized by a commitment to improving cell therapy techniques and enhancing the efficacy of treatments.

Collaborations

Guokui Qin collaborates with talented individuals such as Sean H Kevlahan and Andrew Ball, contributing to a dynamic environment that fosters innovation and research.

Conclusion

Guokui Qin's contributions to cell separation and T lymphocyte expansion are invaluable to the medical community. His patents reflect a dedication to advancing therapeutic techniques that can improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…